Bahrain vs Indonesia: Share of E. coli infections resistant to cephalosporins
Bahrain
63.0%
in 2022
Indonesia
69.7%
in 2022
Bahrain rank
9th
Indonesia rank
8th
Share of E. coli infections resistant to cephalosporins over time
- Bahrain
- Indonesia
How they compare
Indonesia currently reports 69.7% against 63.0% in Bahrain, a difference of 6.7%.
That makes Indonesia's figure about 1.1 times Bahrain's.
Across all 5 years both countries report, Indonesia has been ahead every year.
Bahrain ranks 9th and Indonesia ranks 8th of 46 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.5% | 71.0% | 22.5% | Indonesia |
| 2020s | 59.9% | 72.2% | 12.2% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bahrain or Indonesia?
- Indonesia, at 69.7% against 63.0% in Bahrain as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bahrain and Indonesia?
- 6.7%, with Indonesia ahead.
- How many years of comparable data are there for Bahrain and Indonesia?
- 5 years are reported by both, from 2018 to 2022.
- How do Bahrain and Indonesia rank globally for share of e. coli infections resistant to cephalosporins?
- Bahrain ranks 9th and Indonesia ranks 8th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).